Ушбу иш иқтибос қилган ишлар

84 та иш

Иш: Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer

CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho +1
Шарҳ мақола20224 иқтибос
ABI
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Diana Gumber, Leo D. Wang
Шарҳ мақола20224 иқтибос
ABI
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi +2
Шарҳ мақола20244 иқтибос
ABI
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando +34
Мақола20182 иқтибос
ABI
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Michael D. Buck, David O’Sullivan, Ramon I. Klein Geltink +16
Мақола20162 иқтибос
ABI
Acetate Promotes T Cell Effector Function during Glucose Restriction
Jing Qiu, Matteo Villa, David E. Sanin +22
Мақола20192 иқтибос
ABI
A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging
Marvin E. Tanenbaum, Luke A. Gilbert, Lei S. Qi +2
Мақола20142 иқтибос
ABI
Memory T cells: strategies for optimizing tumor immunotherapy
Qingjun Liu, Zhongjie Sun, Ligong Chen
Шарҳ мақола20202 иқтибос
ABI
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner, Rosalie M. Sterner
Шарҳ мақола20212 иқтибос
ABI
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen +24
Мақола20212 иқтибос
ABI
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
Lupeng Ye, Jonathan J. Park, Lei Peng +17
Мақола20222 иқтибос
ABI
Defining ‘T cell exhaustion’
Christian U. Blank, W. Nicholas Haining, Werner Held +15
Шарҳ мақола20192 иқтибос
ABI
Targeted Methylation and Gene Silencing of VEGF-A in Human Cells by Using a Designed Dnmt3a–Dnmt3L Single-Chain Fusion Protein with Increased DNA Methylation Activity
Abu Nasar Siddique, Suneetha Nunna, Arumugam Rajavelu +7
Мақола20122 иқтибос
ABI
Editing the epigenome: technologies for programmable transcription and epigenetic modulation
Pratiksha I. Thakore, Joshua B. Black, Isaac B. Hilton +1
Шарҳ мақола20162 иқтибос
ABI
Comparison of Cas9 activators in multiple species
Alejandro Chavez, Marcelle Tuttle, Benjamin W. Pruitt +11
Мақола20162 иқтибос
ABI
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons +35
Мақола20182 иқтибос
ABI
Gene Editing and Genotoxicity: Targeting the Off-Targets
Georges Blattner, Alessia Cavazza, Adrian J. Thrasher +1
Шарҳ мақола20202 иқтибос
ABI
CRISPR activation and interference screens decode stimulation responses in primary human T cells
Ralf Schmidt, Zachary Steinhart, Madeline Layeghi +6
Мақола20222 иқтибос
ABI
Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
Ling Zhang, Richard A. Morgan, Joal D. Beane +15
Мақола20152 иқтибос
ABI
Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors
Elnaz Khodabandehloo, Mohammad Rayati, Ehsan Ahmadi +3
Мақола20252 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI